Nerve growth factor is an essential neurotrophic factor required for the growth and maintenance of cutaneous sensory nerves. In the skin, keratinocytes are a signi®cant source of nerve growth factor; however, the regulation of cutaneous nerve growth factor production still remains to be fully understood. In this study we tested the hypothesis that neuropeptides released by cutaneous sensory nerves have the capacity to modulate directly the expression of keratinocyte nerve growth factor, which would have important implications for the maintenance and repair of nerves in the skin. In order to address this question experimentally we examined the effect of the neuropeptides, substance P and neurokinin A, on nerve growth factor expression in human keratinocytes and the murine keratinocyte PAM 212 cell line by quantitative reverse transcriptase±polymerase chain reaction, enzyme-linked immunosorbent assay, and the PC-12 nerve growth factor bioassay. The results of these studies indicated that substance P and neurokinin A can directly induce nerve growth factor mRNA expression and the secretion of bioactive nerve growth factor protein in both human and murine keratinocytes. The speci®city of these responses was demonstrated using neuropeptide receptor antagonists and nerve growth factor blocking antibodies. Additional studies also demonstrated a signi®cant in vivo upregulation of keratinocyte nerve growth factor expression in murine epidermis after the topical application of the neuropeptide releasing agent capsaicin. This is the ®rst report demonstrating the induction of cutaneous nerve growth factor by sensory nerve-derived neuropeptides such as substance P and neurokinin A. This direct effect of the neurosensory system on keratinocyte nerve growth factor production may have important consequences for the maintenance and regeneration of cutaneous nerves in normal skin and during in¯ammation and wound healing.
Nerve growth factor is an essential neurotrophic factor required for the growth and maintenance of cutaneous sensory nerves. In the skin, keratinocytes are a signi®cant source of nerve growth factor; however, the regulation of cutaneous nerve growth factor production still remains to be fully understood. In this study we tested the hypothesis that neuropeptides released by cutaneous sensory nerves have the capacity to modulate directly the expression of keratinocyte nerve growth factor, which would have important implications for the maintenance and repair of nerves in the skin. In order to address this question experimentally we examined the effect of the neuropeptides, substance P and neurokinin A, on nerve growth factor expression in human keratinocytes and the murine keratinocyte PAM 212 cell line by quantitative reverse transcriptase±polymerase chain reaction, enzyme-linked immunosorbent assay, and the PC-12 nerve growth factor bioassay. The results of these studies indicated that substance P and neurokinin A can directly induce nerve growth factor mRNA expression and the secretion of bioactive nerve growth factor protein in both human and murine keratinocytes. The speci®city of these responses was demonstrated using neuropeptide receptor antagonists and nerve growth factor blocking antibodies. Additional studies also demonstrated a signi®cant in vivo upregulation of keratinocyte nerve growth factor expression in murine epidermis after the topical application of the neuropeptide releasing agent capsaicin. This is the ®rst report demonstrating the induction of cutaneous nerve growth factor by sensory nerve-derived neuropeptides such as substance P and neurokinin A. This direct effect of the neurosensory system on keratinocyte nerve growth factor production may have important consequences for the maintenance and regeneration of cutaneous nerves in normal skin and during in¯ammation and wound healing. Key words: keratinocyte/nerve growth factor/neuroin¯ammation/neuropeptides. J Invest Dermatol 117:1075±1082, 2001 N erve growth factor (NGF) is the ®rst isolated and best characterized member of the neurotrophin (NT) family of growth factors (Cohen et al, 1954; Levi-Montalcini, 1987) , which includes brainderived neurotrophic factor (BNDF) (Barde et al, 1982) , NT-3 (Maisonpierre et al, 1990) , NT-4 (Hallbook et al, 1991) , and NT-5 (Berkemeier et al, 1991) . NGF is detected in neurons of the central and peripheral nervous system (Korsching and Thoenen, 1983; Korsching et al, 1985; Heumann et al, 1987b) as well as in a variety of other non-neuronal cell types such as B and T lymphocytes (Santambrogio et al, 1994) , mast cells (Leon et al, 1994) , ®broblasts, and Schwann cells (Heumann et al, 1987a; Matsuoka et al, 1991; Murase et al, 1992; Hattori et al, 1993) . A signi®cant source of NGF in normal skin appears to be keratinocytes (Tron et al, 1990; Di Marco et al, 1991; Pincelli et al, 1994) . In addition, Langerhans cells (Torii et al, 1997) and dermal microvascular endothelial cells (Gibran NS, 2000, personal communication) have also been reported to express NGF in the skin. There is increasing evidence that the development and maintenance of the neurosensory system in the skin depends on the localized expression of NGF (Otten et al, 1980; Ross et al, 1981; Albers et al, 1994) . Cutaneous NGF production may therefore serve as a key factor in neuronal maintenance, survival, and repair in the skin, especially during cutaneous in¯ammatory responses and wound healing (reviewed in Pincelli and Yaar, 1997; Ansel et al, 1996) .
It is now appreciated that the neurosensory system can modulate a wide range of in¯ammatory and proliferative processes in various tissues by the release of bioactive tachykinins such as substance P (SP) and neurokinin A (NKA) (reviewed in Ansel et al, 1996 Ansel et al, , 1997 Scholzen et al, 1998) . Tachykinin releasing sensory C and Ad ®bers extend from the dorsal root ganglia into the epidermis where they are in direct contact with keratinocytes (Kennedy et al, 1994; Lawson, 1996; Reilly et al, 1997; Schulze et al, 1997 Abbreviations: NGF, nerve growth factor; SP, substance P; NKA, neurokinin A; BDNF, brain-derived neurotrophic factor; NT-3, neurotrophin-3; NT-4, neurotrophin-4; NT-5, neurotrophin-5; NK1R, neurokinin-1 receptor; NK2R, neurokinin-2 receptor. tissue repair (reviewed in Scholzen et al, 1998) . In experimental models of in¯ammation, upregulation of neuropeptide levels in the primary sensory neurons innervating the in¯amed tissue was detected as well as elevated NGF levels in skin (Donnerer et al, 1992; Woolf et al, 1994; Sa®eh-Garabedian et al, 1995) . Although it has been reported that NGF upregulates neuropeptide levels in nerves (Goedert et al, 1981) , the ability of neuropeptides to induce NGF production in skin tissue has not been studied. In this study we test the hypothesis that neuropeptides released by cutaneous sensory nerves may directly promote the local production of NGF, which may be important during cutaneous injury and wound healing.
The effects of SP and NKA are mediated by speci®c neurokinin receptors that have been identi®ed on a number of cell types in the skin, including human and murine keratinocytes. The functionality of these keratinocyte neuropeptide receptors has been demonstrated by neuropeptide induction of neurokinin receptor-mediated speci®c Ca 2+ mobilization and cytokine production in these cells (Brown et al, 1990; Song et al, 1999) . SP is known to preferentially bind to the neurokinin 1 receptor (NK1R) and NKA to the neurokinin 2 receptor (NK2R). As there is signi®cant crossreactivity of these ligand-receptor pairs, SP and NKA can bind to both neurokinin receptors but with diminished af®nities (Regoli et al, 1997) . The murine keratinocyte cell line PAM 212 expresses predominantly NK2R rather than NK1R and therefore both SP and NKA appear to activate murine keratinocytes primarily by activation of NK2R (Song et al, 1999) . In contrast, human keratinocytes express both NK1R and NK2R (Brown et al, 1990) , so SP and NKA stimulate speci®c responses through preferential binding to these neurokinin receptors, respectively.
In this study we examined the ability of the sensory nervederived neuropeptides SP and NKA to modulate keratinocyte NGF expression in both human keratinocytes and the murine keratinocyte cell line PAM 212. Receptor blocking studies were conducted to investigate the speci®city of our observations. Furthermore, the effect of in vivo cutaneous neuropeptide release on keratinocyte NGF production was determined.
MATERIALS AND METHODS
Cell culture conditions and reagents The spontaneously transformed keratinocyte cell line (PAM 212), originally derived from a newborn BALB/C mouse, was generously provided by Dr Stuart Yespa (National Cancer Institute, Bethesda, MD). Cells were cultured in RPMI-1640 media (Mediatech Inc., Herndon, VA) containing 10% fetal bovine serum (Gibco BRL/Life Technologies, Grand Island, NY) and 1% penicillin±streptomycin amphotericin B (PSF, Gibco). Human keratinocytes were isolated from neonatal foreskins at the Emory Skin Diseases Research Core Center as previously described (Boyce and Ham, 1985) and cultured in keratinocyte growth media (Clonetics, Walkersville, MD) supplemented with bovine pituitary extract (Clonetics). PC-12 cells (American Type Culture Collection, ATCC, Rockville, MD), originally derived from rat pheochromocytoma tissue, were cultured in a medium of RPMI 1640, 10% donor horse serum (Sigma, St Louis, MO), 5% fetal bovine serum, and 1% PSF. Cell cultures were maintained at 37°C in humidi®ed incubators with 5% CO 2 . PAM 212 cells and PC-12 cells were passaged at 60±70% con¯uency to avoid differentiation. Human keratinocytes were cultured until passages 3±5 for immediate use.
Before stimulating cells with various concentrations of neuropeptides, proin¯ammatory stimuli, or conditioned media, human keratinocytes were starved in keratinocyte growth media without bovine pituitary extract; PAM 212 cells in RPMI-1640 media containing 1% fetal bovine serum and 1% PSF; and PC-12 cells in RPMI-1640 media containing 1% donor horse serum, 0.5% fetal bovine serum, and 1% PSF for 24 h, respectively. For quantitative polymerase chain reaction (PCR) and enzyme-linked immunosorbent assay (ELISA) studies cells were either left untreated or were treated with NKA or SP (Peninsula Laboratories, Belmont, CA) in concentrations ranging from 0.1 to 100 nM. In some studies, treatment with 50 ng per ml phorbol 12-myristate 13-acetate (PMA, Sigma) served as a positive control. All mediators were diluted in fresh starving media and added directly to the cells. Before stimulating cells with 10 nM SP or NKA cells in selected studies were preincubated for 30 min or 2 h either with a 10 mM solution of the speci®c NK1R antagonist Spantide I (Peninsula; Yanagisawa and Otsuka, 1990) or a 1 mM solution of the speci®c NK2R antagonist GR-94800 (Peninsula; McElroy et al, 1992) , respectively. Spantide was dissolved in 1% acetic acid, GR-94800 in 100% acetone and both were diluted to their ®nal concentration in fresh starving media.
Quantitative reverse transcription±PCR Normal human keratinocytes and murine PAM 212 cells were left untreated or treated with neuropeptide concentrations ranging from 0.1 to 100 nm and harvested after 3 h for total RNA isolation. This time-point was chosen as preliminary experiments had demonstrated that NGF mRNA expression after neuropeptide treatment was highest after 3 h (data not shown). RNA was then subjected to DNAse treatment (Ambion, Austin, TX) for 1 h at 37°C followed by a DNAse inactivation step at 70°C for 10 min and reverse transcribed using AMV reverse transcriptase (Promega, Madison, WI) and random primers (Promega). cDNAs were subjected to PCR utilizing the Perkin Elmer PCR 9600 sequence detection system (Perkin Elmer Applied Biosystems, Foster City, CA) and a SYBR green binding dye (Sybr Green PCR Core Reagents, Perkin Elmer) (Morrison et al, 1998 (Morrison et al, , 1999 Steuerwald et al, 2000) . The following speci®c NGF primers were selected using Primer Express software (Perkin Elmer): human NGF sense primer 5¢-AAGTGCCGG-GACCCAAAT-3¢; human NGF anti-sense primer 5¢-TGAGTTCCA-GTGCTTTGAGTCAA-3¢; mouse NGF sense primer 5¢-ACAGTGTA-TTCAGACAGTACTTTTTTGAGA-3¢; mouse NGF anti-sense primer 5¢-GAGTTCCAGTGTTTGGAGTCGAT-3¢; human and mouse 18 S ribosomal RNA sense primer 5¢-CGGCTACCACATCCAAGGAA-3¢; human and mouse 18 S ribosomal RNA anti-sense primer 5¢-GCTGGAATTACCGCGGCT-3¢. For the ampli®cation of human NGF cDNA a standard ampli®cation program was used (1 cycle of 50°C for 2 min, 1 cycle of 95°C for 10 min, 40 cycles of 95°C for 15 s and 60°C for 1 min), for amplifying PAM 212 NGF cDNA the following modi®cations were made: 1 cycle of 50°C for 2 min, 1 cycle of 95°C for 10 min, 35 cycles of 95°C for 15 s and 60°C for 1 min. Direct detection of the PCR product was monitored by measuring the increase in¯uorescence caused by the binding of SYBR green to doublestranded DNA and the speci®city of the PCR product was veri®ed by melting curve analysis (Ririe et al, 1997) . The PCR product was furthermore sequenced and compared with the published nucleotide sequences verifying that the ampli®ed PCR product indeed corresponds with the published NGF mRNA sequence (Ullrich et al, 1983; Borsani et al, 1990) . Using a standard curve of serial dilutions of an untreated cDNA sample, a relative quantitation of the respective target cDNA expressed in x-fold differences was performed. All quantitations were normalized to an endogenous control (18S ribosomal RNA (Schmittgen and Zakrajsek, 2000) to account for variability in the initial concentration and quality of total RNA and in the conversion ef®ciency of the reverse transcription reaction. Results are representative of three independent assays.
PC-12 Bioassay
To detect the presence of bioactive NGF in untreated and neuropeptide-treated 48 h keratinocyte supernatants, PC-12 bioassays were performed as previously described (Scott et al, 1981; Varilek et al, 1991) . Speci®cally, PC-12 cells were plated in 24-well dishes at de®ned concentrations and stimulated with conditioned 48 h supernatants from neuropeptide-treated keratinocytes after cell attachment. In order to prove the speci®city of the bioassay, neuropeptide-treated keratinocyte supernatants were preincubated with speci®c anti-mouse and human NGF neutralizing antibodies (Roche Diagnostics Corp., Indianapolis, IN) before stimulating PC-12 cells. Untreated PC-12 cells served as a negative control and recombinant NGF (50 mg per ml, Roche) treated PC-12 cells as a positive control. After 48 h bioassays were quanti®ed by counting a minimum of 200 cells in random ®elds per test well followed by determining the percentage of cells bearing neurites. Cells were considered positive for neurite outgrowth if they had one or more processes extending greater than one cell diameter. Counts were done twice, results were calculated as mean of counts and are representative of two independent assays. ELISA studies and protein assay To quantitate secreted NGF by ELISA, 48 h supernatants were collected from untreated and neuropeptide-treated keratinocytes and utilized in a standard sandwich ELISA (Promega). The 48 h time-point was chosen as preliminary experiments had demonstrated that NGF protein secretion after neuropeptide treatment was maximal after 48 h (data not shown). Speci®cally,¯at-bottom 96 well plates were coated using polyclonal antihuman and mouse NGF antibodies. Captured NGF was detected by a second speci®c monoclonal anti-NGF antibody and the amount of speci®cally bound monoclonal antibody was then detected using a species-speci®c antibody conjugated to horseradish peroxidase as a tertiary reactant. The unbound conjugate was removed by washing followed by an incubation with the chromogenic substrate 3,3¢,5,5¢-tetramethyl-benzidine. The colorimetric reaction was stopped by addition of 50 ml 1 M H 2 SO 4 and plates were read on an ELISA reader (Spektramax 250, Molecular Devices Corp., Sunnyvale, CA) at OD 450 nm. A standard protein assay (Bio-Rad Laboratories, Hercules, CA) was used for normalizing the NGF protein content of the supernatants to the total cell lysate protein content. Data were analyzed utilizing Softmax Pro (Molecular Devices Corp.) and Microsoft Excel (Microsoft Corp., Redmond, WA) software. Results were calculated as the mean of three values T SD and are representative of three independent assays. Statistical differences between NGF levels of untreated and treated keratinocyte supernatants were calculated using unpaired Student's t test and p`0.05 was considered signi®cant.
Epicutaneous application of capsaicin Normal female C57BL/6 mice were obtained from Jackson Laboratories (Bar Harbor, ME) and housed in the Emory Animal Facility. To cause the local release of neuropeptides from sensory nerves in the skin, 8 wk old mice were treated on the right ear with a single topical application of capsaicin (Zostrix HP 0.075%); the left ear was not treated. Cutaneous treatment sites and untreated control ears were collected from killed mice after 6, 12, 24, and 48 h, immediately frozen in OCT (Tissue-Tek, Sakura Finetechnical, Torrance, CA) and stored at ±70°C. All animal procedures were approved by the Institutional Animal Care and Use Committee (IACUC) at Emory University (Atlanta, GA).
Immunohistochemistry Cryostat sections of untreated or capsaicintreated mouse skin (thickness: 8 mm) were ®xed in ice-cold acetone, quenched in a 0.3% H 2 O 2 solution and subjected to peroxidase immunostaining using VectaStain elite ABC kit (Vector Laboratories Inc., Burlingame, CA) according to the manufacturer's recommendations. A polyclonal rabbit-anti-mouse-NGF antibody (Santa Cruz Biotechnology, Santa Cruz, CA) was used as a primary antibody (1:100) and normal rabbit IgG (Santa Cruz Biotechnology) as a ®rst step negative control at the same dilution. The primary antibody was detected using a biotinylated goat-anti-rabbit antibody and a preformed streptavidin horseradish peroxidase complex from the VectaStain elite ABC kit. To prevent unspeci®c binding of the secondary antibody, sections were blocked with 10% goat serum in Tris-buffered saline. Sections were stained with a 3,3¢-diaminobenzidine solution (0.35 mg per ml; Sigma FAST, Sigma) and counterstained with Mayer's hematoxylin (Sigma). They were photographed with an Olympus C35 AD-4 camera, mounted on an Olympus BH2 microscope. Photographs of immunohistochemistry sections were scanned on a¯atbed scanner (HP Scan Jet 6100 C, Hewlett Packard, Palo Alto, CA) utilizing Adobe Photoshop software and printed on a high resolution laser printer (Kodak Professional 8670 PS Thermal Printer, Eastman Kodak, Rochester, NY).
RESULTS
NGF mRNA expression is directly upregulated in human and murine keratinocytes by SP and NKA To determine the direct effect of neuropeptides on keratinocyte NGF mRNA expression, SP or NKA (0.1±100 nM) were added to cultures of normal human keratinocytes and murine PAM 212 keratinocytes and mRNA expression was determined by quantitative reverse transcriptase±PCR (Fig 1) . SP was capable of directly upregulating NGF mRNA expression in both human and murine keratinocytes Figure 1 . The neuropeptides SP and NKA modulate NGF mRNA expression in human and murine keratinocytes. Total RNA was isolated from unstimulated cells and 3 h after stimulating cells with 0.1±100 nM SP (A, B) or NKA (C, D). RNA from either human (A, C) or murine keratinocytes (B, D) was then reverse transcribed and subjected to real-time quantitative PCR analysis. PMA (50 ng per ml) treated keratinocytes served as a positive control. To determine the speci®city of the NGF mRNA response, keratinocytes were pretreated with selected neurokinin receptor antagonists (NK1RA = Spantide I, NK2RA = GR-94800) for 2 h and then exposed to SP or NKA treatment at doses that generated the maximal induction of NGF mRNA. The data shown are representative of three independent experiments.
( Fig 1A,B) . In human keratinocytes, maximal NGF mRNA levels were observed after the addition of 1 and 10 nm SP (Fig 1A) , whereas maximal PAM 212 NGF mRNA levels were detected after the addition of 100 nM SP (Fig 1B) . In addition to SP, NKA was also effective in inducing NGF mRNA expression in both human and murine keratinocytes with similar but not identical dose±response curves (Figs 1C,D) . In these studies PMA (50 ng per ml) served as a positive control for the induction of keratinocyte NGF mRNA (Fig 1A±D) . The speci®city of the NGF PCR product was veri®ed by melting curve analysis and sequencing as described in Materials and Methods (data not shown). Additionally, northern blot studies were carried out in selected experiments, which con®rmed the quantitative reverse transcriptase±PCR results (data not shown).
We then determined if the maximal neuropeptide induction of keratinocyte NGF mRNA could be blocked by the addition of speci®c neurokinin receptor (NKR) antagonists. Our results indicated that the induction of keratinocyte NGF mRNA expression in murine PAM 212 keratinocytes by SP and NKA was inhibited by pretreatment of the keratinocytes with the selective NK2R antagonist GR 94800 (Figs 1B, D) . This result is consistent with the observation that PAM 212 cells express only the NK2R, which is the principal receptor for NKA, but also can be activated by SP, which binds to the NK2R with reduced af®nity compared with the NK1R. In contrast to the murine cells, human keratinocytes express both the NK1R and the NK2R. Our blocking studies indicated that human keratinocyte NGF mRNA expression stimulated by SP was only partly blocked by pretreatment with the NK2R antagonist GR 94800 but completely inhibited by pretreatment of cells with the NK1R antagonist Spantide I (Fig 1A) . Therefore, SP induction of human keratinocyte NGF occurs principally by activation of the NK1R (Fig 1A) . Our studies also demonstrated that the induction of human keratinocyte NGF mRNA expression by NKA was only partly blocked by pretreatment with the NK1R antagonist Spantide I, but completely inhibited by pretreatment with the NK2R antagonist GR94800, which is consistent with the fact that NKA primarily binds and activates NK2R on human keratinocytes (Fig 1C) . SP and NKA induce the production of bioactive keratinocyte NGF The effect of SP and NKA on the release of bioactive NGF by murine and human keratinocytes was determined. NGF protein bioactivity was measured in murine and human keratinocyte supernatants of cultured cells treated for 48 h with 0.1±100 nM SP or NKA. Bioactivity was measured in these conditioned keratinocyte supernatants in a standard NGF PC-12 bioassay, which measures PC-12 dendrite growth in response to exogenous NGF (Scott et al, 1981; Varilek et al, 1991) . After 48 h, PC-12 dendrite growth was quanti®ed by determining the percentage of cells bearing neurites (Fig 2, representative photomicrographs in Fig 3) . As indicated in Fig 2, supernatants from human and murine keratinocytes treated with SP or NKA demonstrated notable NGF bioactivity compared with supernatants from the untreated cells. Conditioned supernatants from SP-treated human keratinocytes induced a 15±26% increase in PC-12 dendrite growth when compared with dendrite growth in PC-12 cells that were exposed to medium alone (Figs 2A and 3A) . The optimal dose for inducing this result was 10 nM SP. In contrast, conditioned supernatants from SP-treated murine PAM 212 keratinocyte cultures induced a 7±13% increase in PC-12 dendrite growth with an optimal response occurring after treatment of cells with 100 nM SP (Fig 2B) . The effect of NKA on human and murine keratinocyte NGF bioactivity was then measured. Conditioned supernatants from NKA-treated human keratinocytes demonstrated an induction of dendrite growth by 8±14% compared with PC-12 cells exposed to medium alone (Fig 2C) . Likewise, conditioned supernatants from NKA-treated murine PAM 212 keratinocytes induced PC-12 dendrite growth by 15±38% with an optimal response to 10 nM NKA-treated PAM 212 keratinocyte supernatants ( Fig 2D) . As indicated in Fig 2, the increase in PC-12 dendrite growth in the murine and human studies was speci®cally blocked by preincubating keratinocyte conditioned supernatants with neutralizing human and mouse NGF antibodies, thus demonstrating the NGF speci®city of this response ( Figs 2A±   D and 3B) . PC-12 cells treated with medium alone served as a negative control and recombinant NGF-treated PC-12 cells served as a positive control for these studies ( Figs 2A±D and 3C, D) .
The amount of NGF protein present in untreated or neuropeptide-treated keratinocyte supernatants was then quanti®ed by ELISA. Consistent with our previous PC-12 bioassay studies, a neuropeptide concentration-dependent response curve was demonstrated for secreted NGF in 48 h supernatants of SP-treated human keratinocytes with an optimal response after stimulating the keratinocytes with 10 nM SP (Fig 4A, up to 75 pg per ml) . NKA was capable of stimulating NGF protein secretion up to 45 pg per ml in murine PAM 212 keratinocytes in a concentration-dependent manner with an optimal response observed after the addition of 10 nM NKA to the cultured cells (Fig 4B) . ELISA results with NKA-treated human and SP-treated murine keratinocyte supernatants were consistent with our previous bioactivity studies (data not shown). Statistically signi®cant differences were demonstrated for the NGF protein content in all neuropeptide-treated keratinocyte supernatants over the respective untreated cell supernatants Human keratinocytes were stimulated with 0.1± 100 nM SP (A) and the murine PAM 212 keratinocyte cell line was stimulated with 0.1± 100 nM NKA (B) or left untreated for 48 h at 37°C. PMA-treated human and murine keratinocytes served as a positive control. NGF concentrations in the supernatants were measured by ELISA and results were normalized against total protein concentrations in the respective cell lysates. The speci®city of the NGF protein response was tested by pretreating keratinocytes with speci®c neurokinin receptor antagonists (NK1RA = Spantide I, NK2RA = GR-94800) for 2 h before exposing them to SP or NKA treatment. Statistically signi®cant differences between NGF concentrations in samples from treated and untreated cells were determined by Student's t test as indicated by * (p`0.05). The data shown are representative of three independent experiments conducted in triplicate. To demonstrate the speci®city of the response, the 10 nM SP-conditioned supernatant was preincubated with a speci®c neutralizing antihuman NGF antibody before stimulating the PC-12 cells (B). Treatment of PC-12 cells with recombinant NGF (50 mg per ml) served as a positive control (C). Arrows indicate dendrite growth. Scale bar : 6 mm. VOL. 117, NO. 5 NOVEMBER 2001 ( Fig 4A, B) . Again, PMA-treated human and murine keratinocytes served as a positive control for these studies (Fig 4A, B) . The induction of NGF protein secretion by SP was abrogated in human keratinocytes by pretreatment of cells with the speci®c NK1R antagonist Spantide I (Fig 4A) . In murine PAM 212 keratinocytes the induction of NGF secretion by NKA was speci®cally inhibited to control levels by pretreatment with the NK2R antagonist ( Fig 4B) .
Capsaicin-induced neuropeptide release results in increased epidermal NGF To determine if neuropeptides are capable of upregulating epidermal NGF expression in vivo, C57BL/6 mouse ear skin was left untreated or treated topically with capsaicin (0.075%, Zostrix HP), which causes the local release of neuropeptides from sensory nerves in the skin. After collecting tissue at 6, 12, 18, 24, and 48 h, cryostat sections were subjected to peroxidase immunostaining using a speci®c anti-murine NGF antibody. A faint constitutive NGF expression was observed in the keratinocyte cytoplasm of untreated epidermis (Fig 5A) with some increase in staining 24 h after capsaicin application (Fig 5B) . There was a marked increase in NGF expression in murine epidermal keratinocytes 48 h after capsaicin treatment (Fig 5C) . In Fig 5D, capsaicin-treated ear skin was incubated with normal rabbit serum instead of primary antibody thereby serving as a negative control for these studies. Quantitative reverse transcriptase±PCR data demonstrated that NGF mRNA levels were not upregulated in capsaicin-treated keratinocytes when compared with NGF mRNA levels in untreated keratinocytes (data not shown) suggesting that keratinocyte NGF induction is rather due to a capsaicin-induced neuropeptide release than a direct capsaicin effect.
DISCUSSION
NGF is an important molecule in the cutaneous microenvironment, where it may modulate in¯ammatory responses, cellular growth, and nerve maintenance and repair in skin (reviewed in Ansel et al, 1996; Pincelli and Yaar, 1997) . Various growth factors and cytokines (Lindholm et al, 1988 (Lindholm et al, , 1990 as well as b-adrenergic compounds (Carswell et al, 1992) appear to modulate NGF expression in many noncutaneous tissues. In the skin, proin¯am-matory stimuli such as phorbol ester and ultraviolet B irradiation have been reported to upregulate the expression of keratinocyte NGF (Tron et al, 1990) . Likewise, epidermal barrier disruption by tape stripping or acetone treatment can induce the expression of NGF in murine epidermis (Liou et al, 1997) . Furthermore, signi®cant upregulation of keratinocyte NGF was observed after viral transformation with the human papillomavirus 16, whereas transformation with the simian virus SV40, which induces simple epithelial differentiation, reduces the expression of NGF (Anand et al, 1995) . In cultured human keratinocytes NGF expression is strongly inhibited by the addition of hydrocortisone (Di Marco et al, 1991) . Neuropeptide induction of NGF has not been demonstrated in noncutaneous tissue or in the skin.
In this study we demonstrate that cutaneous sensory nervederived neuropeptides, which are released into the skin during in¯ammation or injury, can directly modulate NGF expression in keratinocytes. The neuropeptides SP and NKA were effective in stimulating NGF mRNA expression in human and murine keratinocytes. Whereas SP induced a concentration-dependent increase in human keratinocyte NGF production, murine keratinocytes demonstrated a maximal NGF mRNA response only after exposure to higher SP concentrations. NKA also induced a concentration-dependent increase in both human and murine keratinocyte NGF. We have previously reported that in contrast to human keratinocytes, which express both the SP high-af®nity NK1R and lesser amounts of NK2R, murine PAM 212 keratinocytes express NK2R but not NK1R (Brown et al, 1990; Song et al, 1999) . Therefore, human keratinocytes can respond to either SP or NKA by activation of their respective high-af®nity receptors NK1R and NK2R. This was supported by receptor blocking studies, which demonstrated that SP primarily binds to NK1R and that NKA principally binds to NK2R in human keratinocytes. As murine keratinocytes only express the NK2R, the relative bioactivity of NKA is higher than SP for the induction of NGF in these cells. Both SP-and NKA-induced NGF mRNA responses are reduced by preincubation with a speci®c NK2RA. Understanding this particular species speci®c difference in neurokinin receptor distribution and respective neuropeptide af®nities in human and murine keratinocytes will facilitate our ability to study the effect of neuropeptide-induced mediators, including NGF in cell culture and in animal models.
This study also demonstrated the presence of bioactive NGF protein in human and murine keratinocyte supernatants that induced signi®cant dendrite growth in PC-12 cells (PC-12 bioassays). Quanti®cation of NGF protein in the same keratinocyte Figure 5 . NGF protein expression in individual mouse skin keratinocytes is increased after capsaicin application. C57BL/ 6 mouse ear skin was either left untreated (A) or treated with topical capsaicin to cause the release of neuropeptides from sensory nerves (B and C). Treated skin was collected after 6 h, 12 h (data not shown), 24 h (B), and 48 h (C) and subjected to peroxidase immunostaining using speci®c antimouse NGF antibodies. Capsaicin-treated skin incubated with normal rabbit IgG instead of ®rst antibody served as a negative control (D). Arrows point to speci®c intracellular NGF staining. Treated skin, which was collected after 6 and 12 h did not show elevated epidermal NGF levels when compared with untreated skin. Scale bar : 6 mm.
supernatants by ELISA revealed that very small quantities (up to 75 pg per ml) are suf®cient to induce a signi®cant biologic response. Furthermore, the ELISA studies corresponded to and con®rmed the pattern of dendrite growth induction observed in respective PC-12 bioassays. The ELISA studies also demonstrated that NGF protein levels were reduced by preincubation with speci®c neurokinin receptor antagonists; however, the relatively long time period between optimal keratinocyte NGF mRNA induction 3 h after neuropeptide treatment and maximal bioactive NGF protein secretion at 48 h may indicate the participation of other nontachykinin mediators in inducing keratinocyte NGF protein secretion. Although an involvement of other neuropeptide or non-neuropeptide mediators can also not be excluded in our in vivo studies demonstrating an upregulation of NGF protein expression in capsaicin-treated mouse skin, it is very likely that sensory-nerve derived substance P and neurokinin A participate in this response. Thus, both our in vivo and in vitro data demonstrating the induction of NGF protein by neuropeptides in human and murine keratinocytes strongly support the importance of our ®ndings for the biology of skin.
Denervation of normally innervated skin results in signi®cantly delayed wound healing (Engin et al, 1996; Richards et al, 1997) . Keratinocyte NGF expression increases during wound healing 1 and external treatment with recombinant NGF on wounds accelerates the wound healing process (Li et al, 1980; Matsuda et al, 1998; Bernabei et al, 1999) . In diseases such as leprosy and diabetes, which lead to an impairment of the cutaneous sensory nervous system, epidermal keratinocytes show a depletion of NGF (Anand et al, 1994 (Anand et al, , 1996 . Furthermore, diabetic mice show decreased sciatic nerve neuropeptide levels and in skin biopsies of neuropathic areas in diabetic patients a reduction of neuropeptide containing nerves can be seen (Tomlinson et al, 1988; Willars et al, 1989; Levy et al, 1992; Fernyhough et al, 1994) . Our studies indicate that there may be a bidirectional relationship between keratinocytes and cutaneous nerves. The new concept that neuropeptides can induce the expression of NGF and, conversely, that an absence of neuropeptides or neuropeptide releasing neurons may lead to decreased levels of NGF may explain, at least in part, the pathophysiologic ®ndings in some peripheral neuropathies.
The results of this study suggest a novel regulatory pathway where cutaneous neuropeptides, which are released after an injurious stimulus from skin nerves, upregulate keratinocyte NGF expression that in turn may regulate nerve repair and regrowth. This concept of direct in¯uence of the cutaneous sensory nervous system on the regulation of keratinocyte NGF contributes signi®-cantly to the understanding of skin biology under physiologic conditions and during disease. 
